◆ 会议时间：2025年2月7-9日
◆ 会议地点：美国 格雷普维恩

◆ 会议简介：

2025年第21届美国诊断和介入肾脏病学会(ASDIN)年会将于2025年2月7-9日在美国格雷普维恩举行。
美国诊断和介入性肾脏病学会(ASDIN)成立于2000年,其使命是促进透析治疗的研究、教育与临床实践，以改善肾病患者的预后。未经许可禁止复制摘录转载本站任何内容-国际医学会议网(lingyuint.com)

ASDIN 2025 - 21st Annual Scientific Meeting of the American Society of Diagnostic and Interventional Nephrology

Date:
February 7-9, 2025

Venue:
GAYLORD TEXAN
1501 Gaylord Trail
Grapevine, TX 76051, USA

摘要征文投稿日期：

All abstract submissions must be submitted NO LATER THAN Monday, November 4, 2024. Submitters will be notified by email of acceptance as soon as possible following review.

点此提交摘要>>>Submit Abstract>>>

Call for Cases

Based on initial scoring, abstract submissions may be assigned to:
- LIVE Podium Presentation
- RapidFire Presentation
- OnDemand Abstract

Podium presentations will be reserved for the top abstract in each category -  US, International and Fellow.

*All Podium and RapidFire presenters are required to register and attend the meeting in-person.
*If submitted as a fellow abstract and selected for Podium or RapidFire, the fellow MUST attend and present.

Abstract Presentations
- Presentations must bear a direct relevance to the field of interventional nephrology and dialysis access.
- Submissions are welcome from medicine, science and industry.
- Submitter will be assumed to be the abstract presenter.
- Podium presentations will be 5 minutes in length.
- RapidFire presentations will be 3 minutes in length.
- Presentations should avoid any commercial bias. 
- There is no limit to the number of abstracts that an individual may submit.
- ASDIN may reject abstracts that are considered inappropriate for any reason.
- Abstracts published or presented prior to the ASDIN conference dates will not be accepted.

Submission Deadline
All abstract submissions must be submitted NO LATER THAN Monday, November 4, 2024. Submitters will be notified by email of acceptance as soon as possible following review.  

Abstract Format/Technical Specs
- Abstracts CANNOT Exceed 3500 CHARACTERS
- Word or PDF file only
- TITLE IN BOLD CAPITAL LETTERS 
- Author name with Surname and Initials, affiliations identified with superscript, using numbers (not letters)
- Affiliations for each author should include Department, Hospital/University, City, State, Country
- Presenting Author should be underlined
- Figures, tables and images may be included in abstract submission, but if accepted, will not be included in JVA abstract publication

Submissions not meeting guidelines may not be reviewed.

Selection Process
All abstracts are subjected to blinded, peer review and are evaluated on quality of the project, abstract content, and relevance.

Abstract Awards
Award selection will be based on the quality of the project and presentation. Podium spots will be given to the top US, International and Fellow abstract submission.

WHO SHOULD ATTEND:

Clinical nephrologist interested in optimizing dialysis access care; established and aspiring interventional nephrologists, interventional radiologists, vascular access surgeons, fellow and residents,
nephrology or advanced-practice nurses involved in dialysis patient care of vascular access management, coding/billing staff, radiological technologists, dialysis technologists,
nephrology practice managers, and access center managers.

◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。